Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year
A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year
A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year
Submitted by
admin
on June 17, 2010 - 9:46am
Source:
WSJ
News Tags:
Avastin
Genentech
Lucentis
macular degeneration
Headline:
A.M. Vitals: Using Cheaper Genentech Eye Drug Could Save $500 Million a Year
Do Not Allow Advertisers to Use My Personal information
